Print this page

Targeted Cancer Therapy

Nordic Nanovector AS is a privately held company based in Oslo, Norway. The company was established in 2009. Our mission is to develop innovative radioimmunotherapeutics that target difficult to treat cancers using the company’s proprietary nanovector targeting technology.

Nordic Nanovector intends to commercialise its product candidates through strategic alliances and partnerships with experienced oncology businesses and by establishing its own sales and marketing capabilities in selected markets.

July 7, 2014
Nordic Nanovector: Listing on NOTC
Press Relase 20/2014. See link for details.

July 1, 2014
Nordic Nanovector AS: Change in the Board
(Press Release 19/2014). See link for details.

June 27, 2014
Extraordinary General Meeting held in Nordic Nanovector AS
(Press Release 18/2014). See link for details.
See Minutes of Extraordinary General Meeting

Next page: About us